BRIEF published on 02/12/2026 at 18:05, 4 days 3 hours ago THX Pharma and Biocodex conclude a major strategic agreement Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex
BRIEF published on 02/12/2026 at 18:05, 4 days 3 hours ago THX Pharma annonce un webinaire sur son accord stratégique avec Biocodex Webinaire Accord Stratégique Batten-1 THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 4 days 3 hours ago THX Pharma et Biocodex concluent un accord stratégique majeur Webinaire Accord Stratégique THX Pharma Médicaments Neurologiques Biocodex
BRIEF published on 02/12/2026 at 18:05, 4 days 3 hours ago THX Pharma Announces Webinar on Strategic Agreement with Biocodex Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 4 days 3 hours ago THX Pharma organise un webinaire pour commenter son accord stratégique avec Biocodex THX Pharma annonce un webinaire pour discuter de son accord avec Biocodex portant sur le développement de traitements pour les maladies neurologiques rares Webinaire Accord Stratégique Maladies Neurologiques Rares THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 4 days 3 hours ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 6 days 3 hours ago Accord de licence stratégique pour les traitements des maladies rares Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 6 days 3 hours ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 6 days 3 hours ago Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF published on 02/10/2026 at 18:05, 6 days 3 hours ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
Published on 02/14/2026 at 01:00, 2 days 20 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 2 days 23 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/16/2026 at 20:20, 1 hour 36 minutes ago Oilmar DMCC launches "10 Years, 10 Charities, One Responsibility" initiative
Published on 02/16/2026 at 19:26, 2 hours 30 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/16/2026 at 19:00, 2 hours 57 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 09 FEVRIER 2026 au 13 FEVRIER 2026
Published on 02/16/2026 at 17:45, 4 hours 12 minutes ago Cegedim : Déclaration d'actions et de droits de vote au 31 janvier 2026
Published on 02/16/2026 at 17:43, 4 hours 14 minutes ago Aéroports de Paris S.A - Trafic du mois de Janvier 2026
Published on 02/16/2026 at 17:43, 4 hours 14 minutes ago Aéroports de Paris S.A - January 2026 traffic figures
Published on 02/16/2026 at 17:40, 4 hours 17 minutes ago Eiffage renforce sa présence en Allemagne avec l’acquisition des actifs de Claus Heinemann Elektroanlagen
